HDAC9 and endometrial cancer: The results showed that HDAC inhibitors including vorinostat and valproic acid had potent effects on the inhibition of cell growth in all endometrial cancer cell lines, with G0/G1 or G2/M arrest found after administration of HDAC inhibitors, leading to a significant increase in apoptosis (34).